Debbie Rose

About Debbie Rose

NEXT DESIRED POSITION: Rare disease or unique Biologic Leadership, MSL, Market Access and…

Experience

1. Territory Business Manager, Rare Disease, Hepatology Gastroenterology

   Intercept Pharmaceuticals

   May 2021 — Present

   Highly Specialized sales of an Autoimmune, Rare, non-viral, progressive liver disease therapy in Hepatology and Gastroenterology,(RNA Transcriptase Agonist). Disease state trained on NASH, non-alcoholic steatohepatitis. Covering all major teaching hospitals: DUKE, UNC, WakeForest, ECU, and Southern Virginia. Account Management. Account Management. KOL Development. HUB/Specialty pharmacy, with Limited Distribution Network. Matrix teamwork with Reimbursement for complex pull-through process. T2 2023, ranked #1/9 Mid-Atlantic Region for NBRX, and #1/9 in New Enrollments, 170% to goal,#3/55 Nationally ranked 2022 Associate Director Key Accounts Preceptorship 2022 Rising Star National Sales Award (National Sales Ranking of Top 9) T2 2022 #4/54 National Ranking,#1 in Region, 3065% increase in Sales T1 2022 NBRX growth of 2500%,#1 Region Appointed to National Field Leadership Board, 2022, 2023 T3, 2021 Growth of new enrollments by 200%, ranked #2/54 Nationally,#1/9 in Region Growth of new prescribers by 50%, ranked #1/9 Growth of NBRx by 52% T2 2021 Grew new prescribers by 200%,#1/9

Skills

• Kol Development
• Sales Force Development
• Dermatology
• Infectious Diseases
• Biologics
• Allergy
• Product Launch
• Gastroenterology
• Ob/Gyn
• Psychiatry
• Orthopedic
• Capital Equipment
• Oncology
• Managed Care
• Pharmaceutics
• Sales Operations
• Sales Effectiveness
• General Surgery
• Gi
• Cardiology
• Selling Skills
• Cancer
• Selling
• Diabetes
• Healthcare
• Pain Management
• Surgeons
• Ent
• Operating Room
• Urology
• Nephrology
• Pharmaceutical Sales
• Pharmaceutical Industry
• Medicine
• Infection
• Endocrinology
• Osteoporosis
• Hematology
• Pulmonology
• Rheumatology